Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||
| Net Income | 223 | -7,839 | -5,971 |
| Depreciation Amortization | 305 | 934 | 644 |
| Accounts receivable | -1,174 | N/A | 977 |
| Accounts payable and accrued liabilities | 953 | N/A | 286 |
| Other Working Capital | 108 | 3,067 | 2,071 |
| Other Operating Activity | -1,187 | 405 | -960 |
| Operating Cash Flow | $-772 | $-3,433 | $-2,953 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -10 | -10 |
| Investing Cash Flow | $N/A | $-10 | $-10 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 8,942 | N/A | 5,372 |
| Debt Repayment | N/A | N/A | -4 |
| Common Stock Issued | 14 | N/A | 45 |
| Other Financing Activity | 0 | 5,765 | -93 |
| Financing Cash Flow | $8,956 | $5,765 | $5,320 |
| Exchange Rate Effect | N/A | -23 | -4 |
| Beginning Cash Position | 5,189 | 2,890 | 2,890 |
| End Cash Position | 13,373 | 5,189 | 5,243 |
| Net Cash Flow | $8,184 | $2,299 | $2,353 |
| Free Cash Flow | |||
| Operating Cash Flow | -772 | -3,433 | -2,953 |
| Capital Expenditure | N/A | N/A | -10 |
| Free Cash Flow | -772 | -3,433 | -2,963 |